Isoniazid Mono Resistance: Changing Trends in Drug Resistant Pulmonary Tuberculosis. – A Case Series of 3 Patients
Keywords:INH mono resistance, LPA, MDR TB.
Drug resistant tuberculosis is a major public health concern in many countries including India, Isoniazid
resistance (INH) accounts for 7.2 % of new cases globally.1
In our case series 3 patients had INH mono
resistance out of which 2 patients had no previous history anti tuberculosis therapy (ATT). All 3 patients
received 6 months of standard regimen under National Tuberculosis Elimination Programme (NTEP).
All patients showed clinical improvement. INH mono resistance diagnosis is often delayed due to lack of
infrastructure of 1st line probe assay (LPA) at various centres. INH mono resistance if diagnosed early can
also help in prevention of Multi drug resistant tuberculosis (MDR TB)
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions